1. Home
  2. DCOM vs BCRX Comparison

DCOM vs BCRX Comparison

Compare DCOM & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dime Community Bancshares Inc.

DCOM

Dime Community Bancshares Inc.

SELL

Current Price

$41.89

Market Cap

1.9B

Sector

Finance

ML Signal

SELL

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$7.47

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DCOM
BCRX
Founded
1864
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
DCOM
BCRX
Price
$41.89
$7.47
Analyst Decision
Buy
Buy
Analyst Count
5
11
Target Price
★ $47.80
$20.45
AVG Volume (30 Days)
353.0K
★ 5.4M
Earning Date
10-20-2026
11-04-2026
Dividend Yield
★ 2.37%
N/A
EPS Growth
329.09
★ 381.40
EPS
★ 2.40
N/A
Revenue
$19,907,000.00
★ $25,186,000.00
Revenue This Year
$16.16
N/A
Revenue Next Year
$14.21
$3.71
P/E Ratio
$17.58
★ N/A
Revenue Growth
★ 19.03
N/A
52 Week Low
$25.64
$6.23
52 Week High
$44.89
$11.22

Technical Indicators

Market Signals
Indicator
DCOM
BCRX
Relative Strength Index (RSI) 50.70 40.40
Support Level $39.64 N/A
Resistance Level $43.38 $8.83
Average True Range (ATR) 1.01 0.38
MACD -0.13 -0.03
Stochastic Oscillator 7.25 12.58

Price Performance

Historical Comparison
DCOM
BCRX

About DCOM Dime Community Bancshares Inc.

Dime Commercial Bancshares Inc is the holding company for Dime Commercial Bank, a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: